SCHEMBL17548855

SCHEMBL17548855

c1ccc(-n2c3ccccc3c3cc4c(cc32)sc2c3ccccc3c3[nH]c5ccccc5c3c42)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.40
▸ ATM Q13315 1/20 0.40
▸ L3MBTL1 Q9Y468 1/20 0.40
▸ MEN1 O00255 2/20 0.37
▸ MAPT P10636 2/20 0.37
▸ KMT2A Q03164 2/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ GABRA4 P48169 1/20 0.35
▸ GABRE P78334 1/20 0.35
▸ GABRA6 Q16445 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19325130 0.93 MEN1 (0.34) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19325075 0.91 MEN1 (0.40) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19320186 0.89 CDK5 (0.41) KDM4EMEN1MAPTKMT2ARAB9A
SCHEMBL19325133 0.89 MAP3K9 (0.34) MEN1MAPTKMT2ARAB9AGABRP
SCHEMBL19325132 0.89 MEN1 (0.34) MEN1MAPTKMT2ARAB9AGABRP
SCHEMBL19320176 0.88 KDM4E (0.41) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19320182 0.87 MEN1 (0.34) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19320109 0.86 MEN1 (0.45) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19325048 0.86 MEN1 (0.38) KDM4EATML3MBTL1MEN1MAPT
SCHEMBL19320190 0.86 MEN1 (0.33) KDM4EATML3MBTL1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same DUK SAN NEOLUX CO., LTD. (KR) 2019-08-13 — — US disclosed
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same DUK SAN NEOLUX CO., LTD (KR) 2019-04-04 — — US disclosed
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME DUK SAN NEOLUX CO., LTD (KR) 2017-09-07 — — US disclosed
WO-2016032150-A2 COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2016-03-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170256719-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRICAL ELEMENT USING COMPOUND, AND ELECTRONIC DEVICE COMPRISING SAME ORAI2, VDAC2, PIEZO1 KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885
US-20190103561-A1 Compound For Organic Electronic Element, Organic Electrical Element Using Compound, And Electronic Device Comprising Same ORAI2, VDAC2, PIEZO1 KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885
US-10381574-B2 Compound for organic electronic element, organic electrical element using compound, and electronic device comprising same ORAI2, VDAC2, PIEZO1 KDM4E 594/4885ATM 2903/4885L3MBTL1 783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback